相关实验视频
Updated: Jul 16, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.4K
循环RNA EIF3I通过与AUF1相互作用以增加Cyclin D1的产量来促进乳头甲状腺癌的进展
Xuelin Yao1, Hanyuan Liu2, Zhen Wang1
1Department of Endocrinology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Oncogene
|September 11, 2023
概括
循环真核转化启动因子3子单元I (circEIF3I) 促进了乳头甲状腺癌 (PTC) 的进展. 它通过与AUF1相互作用稳定Cyclin D1mRNA,突出circEIF3I作为PTC的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 循环RNAs (circRNAs) 调节人类癌症的发展.
- 皮毛甲状腺癌 (PTC) 中circRNAs的作用尚未完全理解.
研究的目的:
- 研究hsa_circ_0011385 (circEIF3I) 在乳头甲状腺癌 (PTC) 的功能和机制.
主要方法:
- 在PTC单元中识别circEIF3I.
- 在体外和体内进行了功能增加和丧失的研究.
- 通过细胞质局部化和蛋白质分析研究分子相互作用.
主要成果:
- circEIF3I更稳定,并且位于PTC细胞的细胞质中.
- circEIF3I促进PTC细胞的增殖,细胞循环,迁移和入侵.
- circEIF3I与AUF1相互作用,减少Cyclin D1mRNA的降解并增加蛋白质的产生.
结论:
- circEIF3I在PTC进展中发挥着至关重要的作用.
- circEIF3I代表了对乳头甲状腺癌的潜在治疗点.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K

